Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0358420110540100599
Korean Journal of Obstetrics and Gynecology
2011 Volume.54 No. 10 p.599 ~ p.604
Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for in vitro fertilization: A comparative study
Choo Youn-Sil

Han Ae-Ra
Yang Seung-Heon
Sung Na-Young
Cha Sun-Hwa
Kim Hye-Ok
Park Chan-Woo
Song In-Ok
Koong Mi-Kyoung
Kang Inn-Soo
Yang Kwang-Moon
Abstract
Objective:To evaluate whether oral contraceptive pill (OCP) pretreatments in gonadotropin-releasing hormone (GnRH) antagonist ovarian stimulation protocols takes positive effects on in vitro fertilization (IVF) outcomes in respect to retrieved oocyte number, oocyte maturation rate, fertilization rate, good quality embryo rate, cycle cancellation rate, pregnancy rate and clinical abortion rate.

Methods:A total of 194 cycles using GnRH antagonist protocol was performed at infertility clinic of our institute from September 1st, 2009 to February 28th, 2010. The medical records of GnRH antagonist protocols for IVF with or without OCP pretreatment in our IVF unit were retrospectively analyzed. We compared the IVF outcomes between OCP pretreated (n=41) and no pretreatment group (n=153).

Results:In cycles with OCP pretreated group, the total used dosage of gonadotropin (3019.38¡¾1379.00 IU) were higher than that of no pretreatment group (2551.52 ¡¾ 1157.05 IU, P = 0.054). The duration of ovarian stimulation in OCP pretreated group (11.5 ¡¾ 2.0) was significantly longer than that of control group (9.5 ¡¾ 1.9, P = 0.000). The number of gained total embryo (2.8¡¾0.9 vs. 2.5¡¾1.0, P = 0.055) and fertilization rate (77.2% vs. 65.5%, P = 0.017) were significantly higher in OCP pretreated group. There is no significant difference in pregnancy rate between two groups (39.4% vs. 30.0%, P = 0.304).

Conclusion:OCP pretreatment before GnRH antagonist protocol for IVF appears not to have reliable benefit in terms of IVF outcomes. Well-controlled and large-scaled studies are needed.
KEYWORD
Gonadotropin-releasing hormone antagonist, Oral contraceptive pill pretreatment, Ovarian stimulation, In vitro fertilization
FullTexts / Linksout information
  
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø